Malignancies induce a general immune response. The tumor micro‑environment consists of a variety of immune cells, such as:
  • T cells
  • NK cells
  • B cells
  • Dendritic cells
  • Macrophages
  • Monocytes

Image from The Johanna Joyce Lab, Memorial Sloan Kettering Cancer Center

Myloid cells are a certain type of immune cell which emanate from stem cells in the bone marrow and travel to the site of the tumor.
Cancer cells impede the normal development of these myeloid cells and subvert their usual function.
Once corrupted by the cancer these cells engage in immune‑suppressive activities, and become known as Myeloid Derived Suppressor Cells (MDSCs). 

Image from OncLive, Myeloid Cell Subtype Attracts Growing Interest as Immune System Target

MDSCs are the subject of ongoing cutting-edge research and have been targeted by the newest immunotherapy drugs.
ITUS has identified certain sub-classes of MDSCs as being diagnostic in nature and has developed proprietary protocols for detecting the cells in the blood of cancer patients.
In addition to MDSCs, ITUS is evaluating sub-classes of other immune cells in its analysis.

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

ITUS Corporation to Present at the 3rd Annual Disruptive Growth & Healthcare Conference Hosted by RHK Capital and ReedSmith


ITUS Presentation to Special Meeting of Stockholders


ITUS and Serametrix Announce Results of a Blinded Prostate Cancer Study


Cancer Fact: Breast cancer accounts for 11.9% of cancer incidences worldwide.